NAFLD and NASH in postmenopausal women: implications for diagnosis and treatment
JK DiStefano - Endocrinology, 2020 - academic.oup.com
Nonalcoholic fatty liver disease (NAFLD) prevalence in women is increasing worldwide.
Women of reproductive age have lower rates of NAFLD compared with men; however, this …
Women of reproductive age have lower rates of NAFLD compared with men; however, this …
NAFLD as a sexual dimorphic disease: role of gender and reproductive status in the development and progression of nonalcoholic fatty liver disease and inherent …
S Ballestri, F Nascimbeni, E Baldelli, A Marrazzo… - Advances in …, 2017 - Springer
Nonalcoholic fatty liver disease (NAFLD) spans steatosis through nonalcoholic
steatohepatis, cirrhosis, and hepatocellular carcinoma (HCC) associated with striking …
steatohepatis, cirrhosis, and hepatocellular carcinoma (HCC) associated with striking …
[HTML][HTML] Estrogen as a key regulator of energy homeostasis and metabolic health
Over the last two decades, it has become evident that estrogens preserve the integrity of
energy homeostasis at central and peripheral levels. Estrogen deficiency, such as that …
energy homeostasis at central and peripheral levels. Estrogen deficiency, such as that …
Polycystic ovarian syndrome (PCOS): Long-term metabolic consequences
P Anagnostis, BC Tarlatzis, RP Kauffman - Metabolism, 2018 - Elsevier
Polycystic ovary syndrome (PCOS) is the most common endocrine disorder in women during
their reproductive ages, associated with a plethora of cardiometabolic consequences, with …
their reproductive ages, associated with a plethora of cardiometabolic consequences, with …
Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guideline
Objective: The aim was to formulate practice guidelines for the diagnosis and treatment of
polycystic ovary syndrome (PCOS). Participants: An Endocrine Society-appointed Task …
polycystic ovary syndrome (PCOS). Participants: An Endocrine Society-appointed Task …
Nonalcoholic fatty liver disease in adults: current concepts in etiology, outcomes, and management
T Marjot, A Moolla, JF Cobbold, L Hodson… - Endocrine …, 2020 - academic.oup.com
Nonalcoholic fatty liver disease (NAFLD) is a spectrum of disease, extending from simple
steatosis to inflammation and fibrosis with a significant risk for the development of cirrhosis. It …
steatosis to inflammation and fibrosis with a significant risk for the development of cirrhosis. It …
Non-alcoholic fatty liver disease, obesity and the metabolic syndrome
P Dietrich, C Hellerbrand - Best practice & research Clinical …, 2014 - Elsevier
Nonalcoholic fatty liver disease (NAFLD) is now recognized as the most common cause of
chronic liver disease worldwide. Its prevalence has increased to more than 30% of adults in …
chronic liver disease worldwide. Its prevalence has increased to more than 30% of adults in …
Prevalence and severity of nonalcoholic fatty liver disease in non-obese patients: a population study using proton-magnetic resonance spectroscopy
JL Wei, JCF Leung, TCW Loong… - Official journal of the …, 2015 - journals.lww.com
OBJECTIVES: Some studies suggest that non-obese patients with nonalcoholic fatty liver
disease (NAFLD) may have more severe disease. We aim to study the epidemiology and …
disease (NAFLD) may have more severe disease. We aim to study the epidemiology and …
Sex differences in muscle wasting
LJ Anderson, H Liu, JM Garcia - Sex and gender factors affecting …, 2017 - Springer
With aging and other muscle wasting diseases, men and women undergo similar
pathological changes in skeletal muscle: increased inflammation, enhanced oxidative …
pathological changes in skeletal muscle: increased inflammation, enhanced oxidative …
Targeting nonalcoholic fatty liver disease via gut microbiome-centered therapies
M Koning, H Herrema, M Nieuwdorp… - Gut Microbes, 2023 - Taylor & Francis
Humans possess abundant amounts of microorganisms, including bacteria, fungi, viruses,
and archaea, in their gut. Patients with nonalcoholic fatty liver disease (NAFLD) exhibit …
and archaea, in their gut. Patients with nonalcoholic fatty liver disease (NAFLD) exhibit …